A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials

被引：0
|
作者：
Tatla, Raman
Landaverde, Denis
Victor, Charles
Miles, David
Verma, Sunil
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[4] Mt Vernon Canc Ctr, Northwood, Middx, England
[5] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 27期
关键词：
D O I：
10.1200/jco.2012.30.27_suppl.129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
129
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tailored endpoints: A proposal for design of future clinical trials in metastatic breast cancer (MBC).
    Fontanella, Caterina
    Bonotto, Marta
    Driol, Pamela
    Valent, Francesca
    Gerratana, Lorenzo
    Russo, Stefania
    Andreetta, Claudia
    Minisini, Alessandro
    Mansutti, Mauro
    Sottile, Roberta
    Fasola, Gianpiero
    Puglisi, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Patients with metastatic breast cancer enrolled in phase I clinical trials: Clinical outcomes and cohort trends.
    Weiss, Jennifer
    Gao, Dexiang
    Elias, Anthony D.
    Borges, Virginia F.
    Kabos, Peter
    Davis, S. Lindsey
    Leong, Stephen
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    B. Cabarrou
    L. Mourey
    F. Dalenc
    L. Balardy
    D. Kanoun
    H. Roché
    J. M. Boher
    M. E. Rougé-Bugat
    Thomas Filleron
    Breast Cancer Research and Treatment, 2017, 164 : 505 - 513
  • [34] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    Cabarrou, B.
    Mourey, L.
    Dalenc, F.
    Balardy, L.
    Kanoun, D.
    Roche, H.
    Boher, J. M.
    Rouge-Bugat, M. E.
    Filleron, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 505 - 513
  • [35] Clinical trials in metastatic breast cancer
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (04): : 527 - +
  • [36] QUALITY-OF-LIFE ASSESSMENT IN CANCER CLINICAL-TRIALS - AN INTERVENTION BY ITSELF
    BERNHARD, J
    GUSSET, H
    HURNY, C
    SUPPORTIVE CARE IN CANCER, 1995, 3 (01) : 66 - 71
  • [37] ON ESTIMATING THE DISTRIBUTION FUNCTION FOR QUALITY-OF-LIFE IN CANCER CLINICAL-TRIALS
    KORN, EL
    BIOMETRIKA, 1993, 80 (03) : 535 - 542
  • [38] Outcomes and endpoints of relevance in gynecologic cancer clinical trials
    Madariaga, Ainhoa
    Sanchez-Bayona, Rodrigo
    Herrera, Fernanda G.
    Ramirez, Pedro T.
    Martin, Antonio Gonzalez
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 323 - 332
  • [39] Contribution of clinical trials to improved clinical outcomes for patients with metastatic breast cancer (MBC).
    Lee, Ji Yun
    Lim, Sung Hee
    Lee, Min-Young
    Kim, Haesu
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation
    Sommerer, Claudia
    Zeier, Martin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : 722 - 723
12345